GLAXO
Invest with MTF
Invest Now
Invest in GlaxoSmithKline Pharmaceuticals with 3.24X leverage
Performance
- Low
- ₹2,579
- High
- ₹2,644
- 52 Week Low
- ₹2,220
- 52 Week High
- ₹3,516
- Open Price₹2,604
- Previous Close₹2,604
- Volume44,733
- 50 DMA₹2,499.78
- 100 DMA₹2,559.81
- 200 DMA₹2,626.61
Investment Returns
- Over 1 Month + 10.16%
- Over 3 Month + 3.64%
- Over 6 Month -6.71%
- Over 1 Year + 10.41%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 42.9
- PEG Ratio
- 2.3
- Market Cap Cr
- 43,771
- P/B Ratio
- 25.6
- Average True Range
- 76.56
- EPS
- 59.37
- Dividend Yield
- 1.6
- MACD Signal
- 35.46
- RSI
- 58.13
- MFI
- 68.02
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,583.80
-19.8
(-0.76%)
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹2,520.54
- 50 Day
- ₹2,499.78
- 100 Day
- ₹2,559.81
- 200 Day
- ₹2,626.61
Resistance and Support
2602.13
- R3 2,691.07
- R2 2,667.53
- R1 2,625.67
- S1 2,560.27
- S2 2,536.73
- S3 2,494.87
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,583 As on 19 February, 2026 | 01:28
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹43771.1 Cr As on 19 February, 2026 | 01:28
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 42.9 As on 19 February, 2026 | 01:28
The PB ratio of GlaxoSmithKline Pharmaceuticals is 25.6 As on 19 February, 2026 | 01:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.